Stephen O. Brennan - Concepedia

Author

Stephen O. Brennan

Also Known As

Amy Dear, Andrew D. Laurie, Andrew Laurie, Campbell Sheen, Carl-Erik Dempfle, Hilda Mangos, Jane Wyatt, Michael Mosesson, Paul Ockelford, Peter George

148

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Christchurch Hospital University of Otago Canterbury Health Laboratories University of Canterbury Christchurch Clinical Studies Trust

About

Stephen O. Brennan is an author at Christchurch Hospital specializing in medicine, molecular biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	24	1.2K
2	Natural Sciences	13	16	517
3	Health Sciences	2	2	93
4	Engineering	1	1	10
5	Public Health	1	1	18

Stephen O. Brennan

Publications

Citations

H-Index

Page 1

	Year	Citations
Mutation of Antitrypsin to Antithrombin Maurice C. Owen, Stephen O. Brennan, Jessica H. Lewis, New England Journal of Medicine ThrombopoiesisThrombosisVariant Alpha 1-AntitrypsinBlood PlateletGenetic Disorder	1983	435
Fibrinogen Brescia Stephen O. Brennan, Jane M. Wyatt, Daniela Medicina, American Journal Of Pathology	2000	106
Mutant Fibrinogen Cleared from the Endoplasmic Reticulum via Endoplasmic Reticulum-Associated Protein Degradation and Autophagy Kristina B. Kruse, Amy Dear, Erin Kaltenbrun, American Journal Of Pathology Cell AutophagyMitophagyMutant Fibrinogen ClearedNatural SciencesAutophagy	2006	101
Yeast KEX2 Protease Has the Properties of a Human Proalbumin Converting Enzyme Ian Bathurst, Stephen O. Brennan, Robin W. Carrell, Science	1987	87
A deep intronic mutation in<i>FGB</i>creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment Ryan L. Davis, Vivienne M. Homer, Peter M. George, Human Mutation Aberrant Mrna SplicingGeneticsRna SplicingAntisense Oligonucleotide TreatmentMolecular Biology	2008	62
Fibrinogen Otago: a major α chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage Hayley J. Ridgway, Stephen O. Brennan, James M. Faed, British Journal of Haematology	1997	61
Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val --> Asp). Stephen O. Brennan, Bruce Hammonds, Peter M. George Journal of Clinical Investigation Activation PeptidePathologyMolecular BiologyPeptide ScienceCirrhosis	1995	58
Degradation of Human Adrenomedullin(1-52) by Plasma Membrane Enzymes and Identification of Metabolites L. K. Lewis, Mary W. Smith, Stephen O. Brennan, Peptides Adrenal GlandBiochemistryMedicineBioanalysisHuman Adrenomedullin	1997	58
Latent antithrombin and its detection, formation and turnover in the circulation Alec Mushunje, Gary B. Evans, Stephen O. Brennan, Journal of Thrombosis and Haemostasis InflammationThrombosisThrombopoiesisCardiovascular DiseaseBlood Platelet	2004	52
Circulating proalbumin associated with a variant proteinase inhibitor Stephen O. Brennan, Maurice C. Owen, D. Ross Boswell, Biochimica et Biophysica Acta (BBA) - General Subjects MedicinePathologyLaboratory MedicineVariant Proteinase InhibitorBiomarker Discovery	1984	49

Page 1